Total Payments
$8,522
2024 Payments
$2,056
Companies
29
Transactions
447
Medicare Patients
1,780
Medicare Billing
$253,429
Payment Breakdown by Category
Food & Beverage$8,399 (98.6%)
Education$122.57 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,399 | 440 | 98.6% |
| Education | $122.57 | 7 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,402 | 96 | $0 (2024) |
| ABBVIE INC. | $1,213 | 60 | $0 (2024) |
| Amgen Inc. | $1,107 | 58 | $0 (2024) |
| PFIZER INC. | $686.13 | 45 | $0 (2024) |
| UCB, Inc. | $649.64 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $636.37 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $450.17 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $433.41 | 12 | $0 (2024) |
| Lilly USA, LLC | $340.69 | 18 | $0 (2024) |
| Horizon Therapeutics plc | $285.54 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,056 | 98 | Amgen Inc. ($347.31) |
| 2023 | $2,055 | 102 | ABBVIE INC. ($511.24) |
| 2022 | $1,356 | 74 | Novartis Pharmaceuticals Corporation ($272.95) |
| 2021 | $657.56 | 35 | AbbVie Inc. ($182.27) |
| 2020 | $76.96 | 4 | AbbVie Inc. ($26.60) |
| 2019 | $512.86 | 25 | Amgen Inc. ($154.59) |
| 2018 | $1,789 | 108 | Novartis Pharmaceuticals Corporation ($474.22) |
| 2017 | $18.50 | 1 | PFIZER INC. ($18.50) |
All Payment Transactions
447 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/11/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Rheumatology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $32.31 | General |
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Dermatology | ||||||
| 10/01/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Bone Health | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | Biocon Biologics Inc | Hulio (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 495 | 3,076 | $322,814 | $83,194 |
| 2022 | 9 | 447 | 2,558 | $289,925 | $72,588 |
| 2021 | 11 | 470 | 2,039 | $253,652 | $63,707 |
| 2020 | 9 | 368 | 611 | $105,310 | $33,940 |
Total Patients
1,780
Total Services
8,284
Medicare Billing
$253,429
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 2,040 | $128,520 | $37,166 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 361 | $133,570 | $32,456 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $35,343 | $6,978 | 19.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 158 | 290 | $6,670 | $2,429 | 36.4% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 37 | 144 | $8,393 | $1,989 | 23.7% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 30 | 118 | $6,478 | $1,496 | 23.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 36 | $2,484 | $407.52 | 16.4% |
| 72170 | X-ray of pelvis, 1-2 views | Office | 2023 | 12 | 24 | $1,356 | $271.56 | 20.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 1,680 | $105,840 | $28,928 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 295 | $109,150 | $27,110 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $42,075 | $8,778 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 21 | $10,416 | $2,931 | 28.1% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 38 | 149 | $8,541 | $2,116 | 24.8% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 29 | 115 | $6,186 | $1,431 | 23.1% |
| 73560 | X-ray of knee, 1-2 views | Office | 2022 | 11 | 40 | $2,220 | $509.50 | 23.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 112 | 155 | $3,565 | $460.11 | 12.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 28 | $1,932 | $325.28 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 128 | 271 | $100,270 | $26,279 | 26.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 14 | 1,200 | $75,600 | $19,943 | 26.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 87 | 87 | $48,807 | $10,602 | 21.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 18 | $8,928 | $2,445 | 27.4% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2021 | 25 | 100 | $5,750 | $1,351 | 23.5% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 20 | 74 | $3,996 | $943.62 | 23.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 14 | 14 | $2,546 | $913.64 | 35.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 125 | 201 | $4,623 | $603.00 | 13.0% |
About Dr. Kashif Jafri, M.D
Dr. Kashif Jafri, M.D is a Rheumatology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1598025884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kashif Jafri, M.D has received a total of $8,522 in payments from pharmaceutical and medical device companies, with $2,056 received in 2024. These payments were reported across 447 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($8,399).
As a Medicare-enrolled provider, Jafri has provided services to 1,780 Medicare beneficiaries, totaling 8,284 services with total Medicare billing of $253,429. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Atlanta, GA
- Active Since 05/21/2012
- Last Updated 08/06/2020
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1598025884
Products in Payments
- RINVOQ (Biological) $894.23
- COSENTYX (Biological) $821.35
- Enbrel (Biological) $694.50
- Cimzia (Drug) $599.52
- COSENTYX (Drug) $558.68
- XELJANZ (Drug) $546.79
- BENLYSTA (Biological) $450.17
- SAPHNELO (Biological) $307.33
- SIMPONI ARIA (Biological) $284.42
- KRYSTEXXA (Biological) $266.54
- TALTZ (Drug) $242.94
- SKYRIZI (Biological) $208.18
- TREMFYA (Drug) $182.69
- EVENITY (Biological) $165.33
- ORENCIA (Biological) $149.81
- Otezla (Drug) $149.80
- REMICADE (Biological) $120.67
- LUPKYNIS (Drug) $118.57
- FASENRA (Biological) $105.28
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $98.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Atlanta
Gary Myerson, Md, MD
Rheumatology — Payments: $1.2M
Rheumatology $1.2M
William Wilson, Md, MD
Rheumatology — Payments: $398,508
Rheumatology $398,508
Paul Sutej, Md, MD
Rheumatology — Payments: $343,808
Rheumatology $343,808
Sung Lim, M.d., M.p.h, M.D., M.P.H
Rheumatology — Payments: $124,019
Rheumatology $124,019
Dr. John Goldman, Md, MD
Rheumatology — Payments: $102,184
Rheumatology $102,184
Kimberley Wilson, M.d, M.D
Rheumatology — Payments: $41,792
Rheumatology $41,792